Chemoinformaics analysis of CALCIUM-OXALATE
| Molecular Weight | 128.096 | nRot | 0 |
| Heavy Atom Molecular Weight | 128.096 | nRig | 2 |
| Exact Molecular Weight | 127.942 | nRing | 0 |
| Solubility: LogS | -0.22 | nHRing | 0 |
| Solubility: LogP | -2.797 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 7 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 0 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 29.348 |
| nHD | 0 | BPOL | 3.472 |
| QED | 0.287 |
| Synth | 4.214 |
| Natural Product Likeliness | -0.248 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.738 |
| MDCK | 0.000104296 |
| BBB | 0.319 |
| PPB | 0.158081 |
| VDSS | 0.184 |
| FU | 0.701922 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.045 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.706 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.091 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.042 |
| CL | 1.936 |
| T12 | 0.845 |
| hERG | 0.008 |
| Ames | 0.085 |
| ROA | 0.067 |
| SkinSen | 0.823 |
| Carcinogencity | 0.023 |
| EI | 0.988 |
| Respiratory | 0.043 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.618876 |